The NCRI Molecular Biomarkers Advisory Group
The role of the Molecular Biomarkers Advisory Group is to provide ad hoc advice on biomarkers in late phase clinical trials to CSGs and others. Specifically, members of this virtual group provide advice for trials involving biomarkers and conduct peer-reviews of the biomarker component of trials.
List of members
Professor Roz Banks
Dr Maggie Cheang
Dr Aled Clayton
Dr Eithne Costello-Goldring
Dr Michael Kemp
Dr Hector Keun
Professor Thomas Powles
Professor Jacqui Shaw
Professor Valerie Speirs
Professor Gareth Thomas
Members also consultant with a wider panel of experts who provide further expertise when required.
Areas of expertise:
- Tissue and Biofluid sample collection
- Standard Operating Procedures
- Circulating Tumour Cells
- Cell free DNA
- Epigenetic markers (including DNA methylation)
- Non-coding RNAs
- Serum Proteomics
- Targeted sequencing
- Pharmacodynamic/Pharmacokinetic markers
Those seeking advice from the Molecular Biomarkers Advisory Group with regards to a specific study should complete the NCRI Study Concept Registration Form and tick the appropriate box.
The completed form will be sent to the Chair, who will essentially act as a ‘filter’ and send the trial query to a relevant member of the Advisory Group.
Should you require more generic advice, please contact the NCRI Advisory Group Coordinator.
The current annual report from the Molecular Biomarkers Advisory Group can be found below.